You are here : Home / All Sectors / Healthcare / Pharmaceuticals & Drugs / SYNCOM FORMULATIONS (INDIA)

SYNCOM FORMULATIONS (INDIA)
Intrinsic Value | Fundamental Analysis

Returns | 1W : 21% , 1M : 40.6%,1Y : 283%
BOM : 524470     NSE :     
LT :  
    Long Term Analysis
Fundamentals : Bad
Valuation : Bad [Stock is Expensive]
Debt : Low
Updated:
ST :  
    Short Term Analysis
Quarterly Earnings Trend : Upward
Price Momentum : Upward
Pledged Shares : None or < 25%
Apr 20,2021
Price(EOD): Rs. 4.50
This is the End-of-Day (EOD) Stock Price updated daily by 7 pm IST.
MarketCap: Rs. 355.50 Cr
Stock Market Investing Simplified- The best Video Course by Smart-Investing.in

Check out Industry Peers

Peers & Returns1W1M1Y
SYNCOM FORMULATIONS (INDIA) 21% 40.6% 283%
SUN PHARMACEUTICAL INDUSTRIES 2.8% 10.2% 40.1%
DR REDDYS LABORATORIES 7.8% 18.3% 26.4%
DIVIS LABORATORIES 1.7% 12% 63.2%
CIPLA 7.2% 22.8% 58.3%
BIOCON -1.4% 3.4% 14.3%
AUROBINDO PHARMA 8.5% 17.7% 77.9%
LUPIN 5.1% 6.9% 28.9%
TORRENT PHARMACEUTICALS 1.5% 7.8% 15.5%

FUNDAMENTAL ANALYSIS OF SYNCOM FORMULATIONS (INDIA)

 
Fundamentals Score
[Last Annual Data : Mar2019 | TTM
Trailing Twelve Months (TTM) is calculated using last 4 quarterly data and is a good substitute to track Annual results.
Learn More
]
Show Me the Stocks with Fundamentals better than SYNCOM FORMULATIONS (INDIA) Premium


VALUATION OF SYNCOM FORMULATIONS (INDIA)

 
Valuation Score
RatioValue
P/E
P/B
P/S
25
P/E Calculated based on EPS of 0.18
[ Mar2020 - Standalone Results ]

2.41
P/B Calculated based on Book Value of 1.87
[ Mar2020 - Standalone Results ]

1.97
P/S Calculated based on Revenues of 180.913 Cr
[ TTM - Standalone Results ]

Show Me the Stocks with Valuation better than SYNCOM FORMULATIONS (INDIA) Premium


FAIR VALUE OF SYNCOM FORMULATIONS (INDIA)

 
Model Discount(-)/
Premium(+)
EV/EBIDTA
EV/Sales
Price/Sales
341%
115%
143%

SHARE PRICE MOMENTUM OF SYNCOM FORMULATIONS (INDIA)

DEBT

Year Debt/Equity ratio
Standalone Consolidated
2020
2019
2018
Avg_3yrs
0.01
0.07
0.1
0.06
-
-
-
-
[Last Annual Data : Mar2019]

PLEDGED SHARES

Pledged Shares
0 %
As on : Sep2020

If less than 25%

Good
If between 25% and 50% Neutral
If greater than 50% Bad

QTRLY RESULTS

Standalone 1 Qtr Growth 4 Qtr Growth
Revenue
Op Profit
EBIDT
Net Income
27.82%
4.85%
5.47%
8.51%
60.87%
155.07%
193.73%
186.34%
QtrlyTrend
8
Latest Qtr: Dec2020

SYNCOM FORMULATIONS (INDIA) related INDICES

No BSE index found!
No NSE index found

FAQ [Frequently Asked Questions]


Is good for long term investment?

As on 20-Apr-2021, the Fundamentals of are Poor and hence it's not good for long term investment ! See Financial Performance of SYNCOM FORMULATIONS (INDIA) . Please look at the other parameters such as Valuation, Price Momentum, News & Corporate Governance and/or consult an Investment Advisor before taking an investment decision!

Is UnderValued or OverValued?

As on 20-Apr-2021, is Over Valued and hence NOT a good buying opportunity according to Share Valuation at this time!

What is the Intrinsic Value of ?

As on 20-Apr-2021, the Intrinsic Value of is Rs. 1.85 determined based on Median of the 3 historical models.
Fair Value [Median EV / EBIDTA Model] : Rs. 1.02
Fair Value [Median EV / Sales Model] : Rs. 2.09
Fair Value [Median Price / Sales Model] : Rs. 1.85
Median Fair Value of : Rs. 1.85

Is trading at a Premium or Discount?

As on 20-Apr-2021, is trading at a Premium of 143% based on the Median Intrinsic Value!

Is it right time to buy shares?

As on 20-Apr-2021, is Over Valued and hence NOT a good buying opportunity according to Share Valuation at this time!

What is the Financial Performance of Industry Peers of ?

Check out Financials of Industry Peers using below links:
Financials of SUN PHARMACEUTICAL INDUSTRIES LTD
Financials of DR REDDYS LABORATORIES LTD
Financials of DIVIS LABORATORIES LTD
Financials of CIPLA LTD
Financials of BIOCON LTD
Financials of AUROBINDO PHARMA LTD
Financials of LUPIN LTD
Financials of TORRENT PHARMACEUTICALS LTD
Financials of CADILA HEALTHCARE LTD
Financials of ABBOTT INDIA LTD

What are the Frequent Comparisons with ?

SYNCOM FORMULATIONS (INDIA) LTD vs SUN PHARMACEUTICAL INDUSTRIES LTD vs DR REDDYS LABORATORIES LTD
SYNCOM FORMULATIONS (INDIA) LTD vs SUN PHARMACEUTICAL INDUSTRIES LTD vs DIVIS LABORATORIES LTD
SYNCOM FORMULATIONS (INDIA) LTD vs SUN PHARMACEUTICAL INDUSTRIES LTD vs CIPLA LTD
SYNCOM FORMULATIONS (INDIA) LTD vs SUN PHARMACEUTICAL INDUSTRIES LTD vs BIOCON LTD
SYNCOM FORMULATIONS (INDIA) LTD vs SUN PHARMACEUTICAL INDUSTRIES LTD vs AUROBINDO PHARMA LTD
SYNCOM FORMULATIONS (INDIA) LTD vs SUN PHARMACEUTICAL INDUSTRIES LTD vs LUPIN LTD
SYNCOM FORMULATIONS (INDIA) LTD vs SUN PHARMACEUTICAL INDUSTRIES LTD vs TORRENT PHARMACEUTICALS LTD
SYNCOM FORMULATIONS (INDIA) LTD vs SUN PHARMACEUTICAL INDUSTRIES LTD vs CADILA HEALTHCARE LTD
SYNCOM FORMULATIONS (INDIA) LTD vs SUN PHARMACEUTICAL INDUSTRIES LTD vs ABBOTT INDIA LTD

Open Demat Account & Start Investing
    Affiliate Links

Disclosure

SEBI Research Analyst
The Founder of this website, Mr. Rohit Katiyar is registered with SEBI as a Research Analyst [INH000007377].


All Stocks : A - Z

ALL   A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z